Breaking News

Biophytis Completes €2 Million EUR B Round Financing

October 3, 2012

In an effort to continue the development of its nutraceutical and drug pipeline, Biophytis, a research company that focuses on metabolic disorders and age-related diseases, has raised €2 million EUR ($2.6 million USD) in a B round. Metabrain Research, a spin-off of Merck Serono based in Chilly-Mazarin (south of Paris) joined existing investors Seventure partners and CM-CIC Capital Prive in this round.  
 
Biophytis’ first project, SARCOB, targets the treatment of sarcopenic obesity, in partnership with the Myology Institute and Institute of Cardio-metabolism and Nutrition, both at the University of Pierre and Marie Curie (UPMC), and France’s national agricultural research institute, INRA. The second project, MACULIA, focuses on treating age-related macular degeneration, in collaboration with UPMC’s Institut de la Vision and Iris Pharma, a contract research organization dedicated to ophthalmology. Biophytis leads these two projects, which are sponsored by the Medicen competitivity cluster in the Paris region and which benefit from grants of €2.3 million EUR from a number of European and French local and national government bodies.
 
“The arrival of Metabrain Research as a shareholder marks a step change in a partnership that we have pursued for several years in the SARCOB project,” said Stanislas Veillet, CEO and founder of Biophytis. “It will reinforce our capacity to develop drug candidates derived from our portfolio of nutraceutical active substances, with the aim of signing co-development contracts with pharmaceutical companies.”
 
“The worldwide market of nutrition, where food and drugs meet, has already reached EUR 120 billion annual revenues and is growing at ten per cent a year,” said Isabelle de Cremoux, general manager at Seventure partners. “This makes it very attractive to many industry players. Biophytis is a pioneer in this field and this financing will allow it to accelerate its development with a strategy targeting both drugs and nutrition.”
 
“We believe the strategic partnership between our two companies in both the scientific and marketing fields will allow us to develop a portfolio of innovative projects,” said Valerie Autier, CEO of Metabrain Research. “We will be able to offer full coverage of metabolic diseases through a joint nutraceutical and pharmaceutical approach.”
 
The French and European organizations that are providing grants to the SARCOB and MACULIA projects are FUI (Fonds Unique Interministeriel, a cross-ministry funding body), the European Regional Development Fund, the Essonne and Seine-Saint-Denis departments, the Ile de France region and the city of Paris.

blog comments powered by Disqus
  • Ingredient Authentication in the Lab

    Ingredient Authentication in the Lab

    Richard A. Lovett, JD, PhD, Contributing Writer||January 5, 2016
    Development of standard method performance requirements is critically important work in the dietary supplement industry.

  • Healthy Snacks & Bars: Fresh Opportunities for Growth

    Healthy Snacks & Bars: Fresh Opportunities for Growth

    Robin Wyers, Chief Editor, Innova Market Insights||January 5, 2016
    With an expanding definition of snacking, consumers have an appetite for clean label products that can deliver health benefits.

  • Healthy Immunity Through Stress Reduction

    Healthy Immunity Through Stress Reduction

    Lisa Schofield, Contributing Writer||January 5, 2016
    Addressing chronic stress and anxiety can have a significant effect on the immune system.

  • Frontline Puts Supplements On Defense

    Frontline Puts Supplements On Defense

    Sean Moloughney, Editor||January 26, 2016
    PBS segment questions the safety and effectiveness of common dietary supplements.

  • Smart Fat: High Fat Food For Health

    Smart Fat: High Fat Food For Health

    Lisa Olivo, Associate Editor||January 21, 2016
    Dr. Jonny Bowden outlines the benefits of a high fat, high protein, high fiber diet.

  • Cold-Pressed for Success

    Cold-Pressed for Success

    Lisa Olivo, Associate Editor||January 14, 2016
    Pressed Juicery Founder & CEO talks juice trends for the coming year.